Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) dated March 31, 2016, by
and between EZTD Inc., a Delaware corporation having an address at 6 Yehezkel
Koifman St., Tel Aviv, Israel 68012 (the “Company”), and Compagnie Financiere
Saint Exupery Sicav-Sif having an address at 42 rue de la Vallee, L2661
Luxembourg (the “Purchaser”). The Company and the Purchaser (collectively
referred to herein, the "Parties") agree as follows:

 

ARTICLE 1
PURCHASE AND SALE

 

1.1 Closing.

 

(a) Subject to the terms and conditions of this Agreement, the closing of the
transaction contemplated by this Agreement (the "Closing") shall be held
remotely via the exchange of documents and signatures concurrently with the
execution of this Agreement or such other time as shall be agreed upon, orally
or in writing, by the Purchaser and the Company.

 

(b) Securities Purchased. At the Closing the Company will sell and the Purchaser
will purchase the following securities of the Company for an aggregate purchase
price of $6,000,000 (Six Million U.S. Dollars) (the “Purchase Price”) to be
transferred as set forth on Schedule 1.1(c) attached hereto, as follows:

 

(i)            30,000,000 (Thirty Million) shares of the Company’s Common Stock
$0.001 par value at a price of $0.20 per share corresponding to an aggregate
purchase price of $6,000,000 (Six Million U.S. Dollars); and

 

(ii)           Sixty (60) months warrant to purchase up to an additional
26,666,667 (Twenty Six Million Six Hundred and Sixty Six Thousand and Six
Hundred and Sixty Seven) shares of the Company’s Common Stock $0.001 par value
with an exercise price of $0.225 per share, which will be issued to the
Purchaser at the Closing and will be exercisable only after six months from
Closing (the "Warrant"). No separate consideration shall be paid for the
issuance of the Warrant. The Warrant shall be in the form appended hereto as
Exhibit "A" (the shares issuable upon the exercise of the Warrant are sometimes
referred to hereinafter as the "Warrant Shares" and the Shares and the Warrant
Shares are sometime referred to hereinafter as the "Securities").

 

(c) Closing Deliveries. Subject to the following provisions of this clause, at
or prior to the Closing, the following transactions will take place, all of
which shall be deemed to have occurred simultaneously and no transaction shall
be deemed to have been completed or any document delivered until all such
transactions have been completed and all required documents delivered: (1) the
Purchaser shall pay the purchase price to the Company, by way of a bank transfer
to the Company's account, in immediately available funds, to the bank accounts
set forth on Schedule 1.1 (c), (2) the Company shall issue and allot to the
Purchaser, no later than forty five (45) days following the Closing, the Shares
and the Warrant., and (3) each Party shall deliver to the other Party copies of
resolutions taken by its board of directors (or other similar governing body)
approving the execution and delivery of this Agreement, and all the transactions
contemplated hereunder.

 

THE PURCHASER UNDERSTANDS THAT AN INVESTMENT IN THE SECURITIES INVOLVES A HIGH
DEGREE OF RISK, AND THAT THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFER
AND RESALE. THERE CAN BE NO ASSURANCES THAT THE PURCHASER WILL RECOVER ALL OR
ANY PORTION OF THIS INVESTMENT.

 

 

 

 

ARTICLE 2
REPRESENTATIONS AND WARRANTIES

 

2.1 Representations and Warranties of the Company.

 

(a) Organization and Qualification. The Company is a corporation duly
incorporated, validly existing and in good standing under the laws of the State
of Delaware, with the requisite power and authority to own and use its
properties and assets and to carry on its business as currently conducted.

 

(b) Authorization; Enforcement. The Company has the requisite corporate power
and authority to enter into and to consummate the transactions contemplated
hereby. The execution and delivery of this Agreement by the Company and the
consummation by it of the transactions contemplated hereby, including the
issuance of the Shares and the Warrant hereunder, has been duly authorized by
all necessary action on the part of the Company. This Agreement is the valid and
binding obligation of the Company enforceable against the Company in accordance
with its terms.

 

(c) Issuance of the Securities. The Shares are duly authorized and, when issued
and paid for in accordance with this Agreement, will be duly and validly issued,
fully paid and no assessable. The Warrant Shares, when issued in accordance with
the terms of the Warrant, will be validly issued, fully paid and non assessable.
A summary of the Company's capitalization table is set forth on Schedule 2.1(c)
attached hereto.

 

(d) Material Adverse Changes. Except as listed in Schedule 2.1(d), as of
December 31, 2015, onwards there has not been:

 

(i)            any material adverse change in the assets, liabilities, financial
condition, business or prospects of the Company;

 

(ii)           any damage, destruction or loss, materially affecting the assets,
business, properties, condition (financial or otherwise) of the Company;

 

(iii)          any waiver or compromise by the Company of a material right or of
a material debt owed to it;

 

(iv)          any satisfaction or discharge of any lien, claim or encumbrance or
payment of any obligation by the Company, except in the ordinary course of
business;

 

(v)           any material change or amendment to a material contract or
arrangement by which the Company or any of their respective assets or properties
is bound or subject;

 

(vi)          any material change in any compensation arrangement or agreement
with any employee, officer, director or shareholder of the Company;

 

(vii)         any sale, assignment or transfer of any and all intellectual
property of the Company, including but not limited to, whether or not
patentable, including without limitation, all patents, trademarks, service
marks, trade names, copyrights, trade secrets, information, licenses,
proprietary rights, processes and concepts;

 

 2 

 

 

(viii)        any resignation or termination of employment of any officer or key
employee of the Company; and the Company, to the best of its knowledge, does not
know of any impending resignation or termination of employment of any such
officer or key employee;

 

(ix)           receipt of written notice that there has been a loss of, or
material order cancellation by, any major customer or business associate of the
Company;

 

(x)            any mortgage, pledge, transfer of any interest or equity of any
individual or entity (including without limitation any right to acquire, option,
or right of pre-emption, or right of first refusal) or any mortgage, charge,
pledge, lien, or assignment, or any other encumbrance or security interest or
arrangement of whatsoever nature over or in the relevant property in, or lien,
created by the Company and/or by its subsidiary, with respect to any of their
respective material properties or assets;

 

(xi)           any loans or guarantees made by the Company to or for the benefit
of their respective employees, officers or directors, or any members of their
respective immediate families, other than travel advances and other advances
made in the ordinary course of its business;

 

(xii)          any declaration, setting aside or payment or other distribution
in respect of the share capital of the Company or any direct or indirect
redemption, purchase or other acquisition of any of such share capital by the
Company; or

 

(xiii)         any agreement or commitment by the Company to do any of the
things described in this Section 2.1(d).

 

2.2 Representations and Warranties of the Purchaser.  The Purchaser hereby
represents and warrants as follows:

 

(a) Organization; Authority. If the Purchaser is an entity duly organized,
validly existing and in good standing under the laws of the jurisdiction of its
organization with full right, corporate or partnership power and authority to
enter into and to consummate the transactions contemplated by this Agreement and
otherwise to carry out its obligations hereunder and thereunder. The execution
and delivery of this Agreement and performance by the Purchaser of the
transactions contemplated by this Agreement have been duly authorized by all
necessary corporate or similar action on the part of the Purchaser. This
Agreement has been duly executed by the Purchaser, and is the valid and legally
binding obligation of the Purchaser, enforceable against it in accordance with
its terms. No consent, approval, order or authorization of, or registration,
qualification, designation, declaration or filing with, any governmental
authority, including the U.S. Securities and Exchange Commission, is required on
the part of the Purchaser in connection with the execution and delivery of this
Agreement, or the offer, sale, and delivery of the Securities as contemplated by
this Agreement.

 

(b) Own Account; Investment Intent. The Purchaser is acquiring the Securities as
principal for its own account for investment purposes only and not and will not
acquire the Shares, the Warrant or the Warrant Shares with a view to or for
distributing or reselling them in violation of the Securities Act of 1933, as
amended (the “Securities Act”) or any applicable state securities law, has no
present intention of distributing any of them in violation of the Securities Act
or any applicable state securities law and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding their
distribution of such Securities. The Purchaser understands that the Securities
included therein are “restricted securities” and have not been registered under
the Securities Act or any applicable state securities laws. The Purchaser is
acquiring the Securities and each part thereof hereunder in the ordinary course
of its business.

 

 3 

 

 

(c) Regulation S. The Purchaser makes the following representations related to
Regulation S under the Securities Act: (i) it is not a “U.S. Person” as that
term is defined in Rule 902 of Regulation S under the Securities Act; and
received all communications relating to the issuance of the Shares, and executed
all documents relating thereto, outside the United States; and (ii) it agrees to
resell the Shares, the Warrant and the Warrant Shares only in accordance with
the provisions of Regulation S, or pursuant to another available exemption from
the registration requirements of the Securities Act, and further agrees not to
engage in hedging transactions with regard to such securities unless in
compliance with the Securities Act.

 

(d) Experience of Such Purchaser. The Purchaser, either alone or together with
its representatives, has such knowledge, sophistication and experience in
business and financial matters so as to be capable of evaluating the merits and
risks of the prospective investment in the Securities, and has so evaluated the
merits and risks of such investment. The Purchaser is able to bear the economic
risk of an investment in the Securities (and each part thereof) and, at the
present time, is able to afford a complete loss of such investment.

 

(e) Opportunity to Conduct Due Diligence. The Purchaser was granted the
opportunity to conduct due diligence prior to entering into the transactions
contemplated by this Agreement. The Purchaser has read this Agreement and is
familiar with the terms of the Securities. In making the decision to purchase
the Securities, the Purchaser and the Purchaser’s advisors have, prior to any
sale to the Purchaser, been given access and the opportunity to examine all
books and records of the Company, all contracts and documents relating to the
Company, and an opportunity to ask questions of, and to receive answers from,
the Company and to obtain any additional information necessary to verify the
accuracy of the information provided to the Purchaser. The Purchaser and the
Purchaser’s advisors have been furnished with all materials relating to the
business, finances and operations of the Company and materials relating to the
offer and sale of the Securities that have been requested. The Purchaser is
aware of, and has been advised by the Company that: (i) on February 11, 2016,
the Board of Directors of the Company approved (a) an amendment to the Company's
Certificate of Incorporation to reduce the Company’s authorized Common Stock
from 300,000,000 shares, with a par value of $0.001 per share, to 10,000,000
shares with a par value of $0.03 per share (the “Amendment”), and (b) a 1-for-30
reverse stock split of the Company’s issued and outstanding shares of Common
Stock, such that each 30 shares of Common Stock held by stockholders of record
on or about April 4, 2016 be combined into one share of Common Stock (the
“Reverse Split”); (ii) on February 15, 2016, the stockholders holding a majority
of the Company’s voting power approved the Amendment and Reverse Stock Split by
written consent in lieu of a meeting, in accordance with the Delaware General
Corporation Law; and (iii) on March 14, 2016 the Company filed with the
Securities and Exchange Commission an Information Statement on Schedule 14C
relating to the contemplated Amendment and the Reverse Split. Copies of the (i)
Written Consent of the Board of Directors dated February 11, 2016, approving the
Reverse Split; and (ii) Written Consent of the Stockholders approving the
Reverse Split, are attached hereto as Schedule 2.3(e). The only representations
and warranties being given to the Purchaser by the Company, express or implied,
at law or in equity, with respect to the Company, the Securities and\or the
Company's business, are as explicitly contained in this Agreement.

 

Notwithstanding the foregoing, it is further agreed and understood that the
Purchaser shall have the right to perform additional due diligence with respect
to the Company's financial statements for the year ended December 31, 2015 and
shall have the right to request full access to the relevant books and financial
records in connection with the diligence of such financial statements.

  

(f) Advice. The Company and its counsel have not provided to the Purchaser any
legal, accounting, regulatory or tax advice with respect to the offering
contemplated hereby, and the Purchaser has consulted its own legal, accounting,
regulatory and tax advisors to the extent it deemed appropriate.

 

 4 

 

  

ARTICLE 3
OTHER AGREEMENTS OF THE PARTIES

 

3.1 Transfer Restrictions.

 

(a) The Purchaser hereby acknowledges that the Securities and any part thereof
may only be disposed of in compliance with state and federal securities laws. In
connection with any transfer of Shares, Warrant or Warrant Shares other than
pursuant to an effective registration statement or Rule 144, to the Company or
to an affiliate of a Purchaser or in connection with a pledge, the Company may
require the transferor thereof to provide to the Company an opinion of counsel
selected by the transferor and reasonably acceptable to the Company, the form
and substance of such opinion shall be reasonably satisfactory to the Company,
to the effect that such transfer does not require registration of such
transferred Shares, Warrant or the Warrant Shares under the Securities Act.
Unless the transfer of the Warrant has been registered, no Warrant may be
transferred to any person that is not an “accredited investor.”

 

(b) The Purchaser agrees to the imprinting, so long as is required, of a legend
on any of the Shares, Warrant and Warrant Shares in the following form:

 

[THESE SHARES] [THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS
WARRANT] HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL SATISFACTORY TO THE
COMPANY TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO
THE COMPANY.

 

3.2 Non Compete. Purchaser undertakes that for so long as it is a shareholder of
the Company and for a period of twelve (12) months thereafter, it shall : (i)
not engage in any activity that directly and\or indirectly competes with the
business of the Company, (ii) not hold ownership interest in any firm or
corporation that directly and\or indirectly competes with the Company, other
than passive holdings representing less than five percent (5%) of any such firm
or corporation, and (iii) refrain from any potential conflict of interests with
the Company.

 

3.3 Confidentiality. Subject to applicable law, each Party agrees to keep this
Agreement in strict confidence and that it shall not, without the prior written
consent of the other Party, disclose any information relating to the other Party
other than disclosure to the representatives and\or advisors of such Party, on a
"need to know" basis or as required under applicable law. For the avoidance of
doubt, the aforesaid shall not include any information which: (a) is or becomes
generally available to the general public other than as a result of a breach of
an undertaking hereunder, or (b) is or becomes available to a Party through a
disclosure by a third party.

 

 5 

 

 

ARTICLE 4
MISCELLANEOUS

 

4.1 Fees and Expenses. Each Party shall pay the fees and expenses of its
advisers, counsel, accountants and other experts, if any, and all other expenses
incurred by such Party in connection with this Agreement. Purchaser acknowledges
that the Company may pay a transaction fee to finders.

 

4.2 Notices. Any and all notices or other communications or deliveries required
or permitted to be provided hereunder shall be in writing and shall be deemed
given and effective on the earliest of: (a) the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number or by
email to the email address set forth on the signature page or (b) upon actual
receipt by the Party to whom such notice is required to be given.

 

4.3 Successors and Assigns. This Agreement shall be binding upon and inure to
the benefit of the Parties and their successors. This Agreement is not
assignable by either Party.

 

4.4 Governing Law. All questions concerning the construction, validity,
enforcement and interpretation of this Agreement shall be governed by and
construed and enforced in accordance with the internal laws of the State of New
York without regard to conflict of laws principles. Each Party agrees that all
legal proceedings concerning the interpretations, enforcement and defense of the
transactions contemplated by this Agreement (whether brought against a Party
hereto or its respective affiliates, directors, officers, shareholders,
employees or agents) shall be commenced exclusively in the state and federal
courts sitting in the City of New York. Each Party hereby irrevocably submits to
the exclusive jurisdiction of the state and federal courts sitting in the City
of New York, borough of Manhattan for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or
discussed herein (including with respect to the enforcement of this Agreement).

 

4.5 Entire Agreement; Amendments; Execution. This Agreement represents the
entire agreement between the Parties with respect to the subject matter hereof.
This Agreement may be executed in any number of counterparts and by different
Parties hereto in separate counterparts, each of which when so executed and
delivered shall be deemed to be an original and when a counterpart has been
executed by each of the Parties hereto, all of the counterparts, when taken
together, shall constitute one and the same agreement. This Agreement may not be
modified or amended, and no breach shall be deemed to be waived, unless agreed
to in writing by the Parties.

 

4.6 Survival of Representations. The Purchaser agrees that all of the
warranties, representations acknowledgments, confirmations, covenants and
promises made in this Agreement shall survive its execution and delivery.

 

4.7 Changes in Representations. The Purchaser agrees to notify the Company
immediately of any change in the representations, warranties or information
pertaining to the Purchaser contained herein.

 

[Signature page immediately follows]

 

 6 

 

 

IN WITNESS WHEREOF, the Parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.

 

EZTD, INC.                 By: EZTD                 Name: Shimon Citron        
        Title: CEO                 Compagnie Financiere Saint Exupery Sicav-Sif
          By: /s/ Vincent Cornean   By: /s/ Karl Heinz Dick           Name:
Vincent Cornean   Name: Karl Heinz Dick           Title: Director   Title:
Director

 

 7 

 

 

Exhibit A

  

Warrant Certificate

 

 

 

 

 

 8 

 

  

Schedule 1.1(c)

 

Purchase Price Breakdown and Bank Account Information

 

The Purchase Price shall be wired as follows:

  

The amount of $1,000,000 to the Company's bank account in MEINL Austria as
follows:

 

Account no.

IBAN:

BIC(SWIFT-Code):

Account name:

Bank Name:

Bank Address:

 

The amount of $1,000,000 to the Company's bank account in Israel as follows:

 

Account no.

IBAN:

BIC(SWIFT-Code):

Account name:

Bank Name:

Bank Address:

 

The amount of $4,000,000 to the Company's bank account in London as follows:

 

BANK:

BIC:

ACCOUNT WITH:

ACCOUNT NUMBER:

IN FAVOUR OF:

BIC:

  

FOR FURTHER CREDIT

 

ACCOUNT NAME:

BANK:

IBAN:

SWIFT:

 

 9 

 

 

Schedule 2.1(c)

 

Capitalization Table Summary

 

No. of shares Authorized

 

300,000,000  

No. of Shares issued and Outstanding

 

115,896,000  

No. of Warrants and Options issued and Outstanding

 

66,501,000   No. of Warrants and Options available for issuance (*) 32,807,000  

 

Total Shares and Warrants

 

 

215,204,000

       

 

(*) Consists of 26,572,000 shares issuable upon conversion of outstanding loans;
1,761,000 additional warrants issuable to certain lenders upon conversion of
outstanding loans; and 4,474,000 options available for grant under the 2004
Global Option Program.

 

 10 

 

 

Schedule 2.1(d)

 

  ● The Company's 2016 Operating Budget a copy of which is attached hereto.

 

  ● The Company's Annual Report on Form 10-K for the year ended December 31,
2015, a copy of which is attached hereto.

 

 11 

 

 

Schedule 2.3 (e)

 

  ● Written Consent of the Board of Directors dated February 11, 2016 is
attached hereto.

 

  ● Written Consent of the Stockholders dated February 15, 2016 is attached
hereto.

 

12